/IVITF
IVITF Stock - Invictus MD Strategies Corp.
Healthcare|Drug Manufacturers - Specialty & GenericOTC
$0.00+9900.00%
+$0.00 (+9900.00%) • May 27
65
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.50
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.92
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.00
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for IVITF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.00 – $0.00
TARGET (TP)$0.00
STOP LOSS$0.00
RISK/REWARD1:-1.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.70
52W High$0.00
52W Low$0.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|
| Revenue | $3.57M | $1.93M | $1.96M | $2.63M | N/A |
| Gross Profit | $-2,894,127 | $-1,230,456 | $754,328 | $849,684 | N/A |
| Gross Margin | -81.0% | -63.8% | 38.6% | 32.3% | N/A |
| Operating Income | $-24,820,635.041 | $-14,635,578.922 | $-4,098,170.662 | $-695,128.797 | $-274,989 |
| Net Income | $-27,192,444.986 | $-16,120,816.726 | $-4,325,424.353 | $-72,560.668 | $-707,903 |
| Net Margin | -761.0% | -836.5% | -221.2% | -2.8% | N/A |
| EPS | $-0.35 | $-0.24 | $-0.41 | $-0.18 | $-0.83 |
Company Overview
Invictus MD Strategies Corp. invests in, acquires, and develops synergistic businesses in the cannabis industry in Canada. The company operates through two segments, Sale of Cannabis and Fertilizers. It produces and sells medical cannabis; and plant fertilizers, nutrients, and other supplies for hydroponics, as well as operates medical clinics in Alberta. The company was incorporated in 2014 and is headquartered in Vancouver, Canada.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
IVITFBeat Rate
0%
Last 1 quarters
Avg Surprise
-50.0%
EPS vs Estimate
Beats / Misses
0/1
Last 12 quarters
Latest EPS
$-0.04
Q4 2019
EPS Surprise History
Q2 18
No data
Q2 18
No data
Q3 18
No data
Q4 18
No data
Q2 19
No data
Q2 19
No data
Q3 19
No data
Q4 19
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2024 | Oct 2, 2024 | — | — | — | — |
Q2 2024 | Jun 28, 2024 | — | — | — | — |
Q2 2024 | Apr 3, 2024 | — | — | — | — |
Q1 2024 | Jan 3, 2024 | — | — | — | — |
Q3 2023 | Sep 27, 2023 | — | — | — | — |
Q2 2023 | Jun 30, 2023 | — | — | — | — |
Q1 2023 | Mar 29, 2023 | — | — | — | — |
Q4 2022 | Dec 28, 2022 | — | — | — | — |
Q3 2022 | Sep 28, 2022 | — | — | — | — |
Q3 2022 | Jul 1, 2022 | — | — | — | — |
Q1 2022 | Mar 30, 2022 | — | — | — | — |
Q4 2019 | Dec 29, 2019 | — | $-0.04 | — | — |
Q3 2019 | Sep 27, 2019 | — | $-0.08 | — | — |
Q2 2019 | Jun 28, 2019 | — | $-0.03 | — | — |
Q2 2019 | May 29, 2019 | — | $-0.05 | — | — |
Q4 2018 | Dec 20, 2018 | — | $-0.08 | — | — |
Q3 2018 | Sep 28, 2018 | — | $-0.04 | — | — |
Q2 2018 | Jun 22, 2018 | — | $-0.03 | — | — |
Q2 2018 | May 29, 2018 | — | $-0.05 | — | — |
Q4 2017 | Dec 22, 2017 | $-0.02 | $-0.03 | -50.0% | ✗ MISS |
Latest News
Loading news...
Frequently Asked Questions about IVITF
What is IVITF's current stock price?
Invictus MD Strategies Corp. (IVITF) is currently trading at $0.00 per share. The stock has moved +9900.00% today.
What is the analyst price target for IVITF?
No analyst price targets are currently available for this stock.
What sector is Invictus MD Strategies Corp. in?
Invictus MD Strategies Corp. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.
What is IVITF's market cap?
Invictus MD Strategies Corp. has a market capitalization of $0.00 billion, making it a small-cap company.
Does IVITF pay dividends?
No, Invictus MD Strategies Corp. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorACRDF
Acreage Holdings, Inc.
$0.12
Mkt Cap: $0.0B
ACRHF
Acreage Holdings, Inc.
$0.00
Mkt Cap: $0.0B
CHNC
China Infrastructure Construction Corp.
$0.00
Mkt Cap: $0.0B
GHSI
Guardion Health Sciences, Inc.
$3.25
Mkt Cap: $0.0B
HDRPF
Epsilon Healthcare Limited
$0.00
Mkt Cap: $0.0B
HERTF
Heritage Cannabis Holdings Corp.
$0.00
Mkt Cap: $0.0B
NDVAF
Indiva Limited
$0.02
Mkt Cap: $0.0B
PXMVF
Pixium Vision S.A.
$1.50
Mkt Cap: $0.0B
SEPSF
Asep Medical Holdings Inc
$0.01
Mkt Cap: $0.0B
VVCIF
VIVO Cannabis Inc.
$0.02
Mkt Cap: $0.0B
Explore stocks similar to IVITF for comparison